Simy K Parikh1, William B Young2,3. 1. Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. 2. Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. william.b.young@jefferson.edu. 3. Jefferson Hospital for Neuroscience, Nine Hundred Walnut Street, Second Floor, Suite #200, Philadelphia, PA, 19107, USA. william.b.young@jefferson.edu.
Abstract
Migraine is a prevalent disease with a substantial socioeconomic impact. However, stigma affects social attitude toward migraine, accruing additional burden on individuals with migraine and isolating them from a society that should be supporting them. PURPOSE OF THIS REVIEW: This review will discuss the following concepts: (1) the emergence of stigma toward migraine and its impact on medical care; (2) internalized stigma among those with migraine and its detrimental effect on quality of life and patient-physician relationships; (3) the structural impact of stigma on research funding, workplace support, and specialized care; and (4) strategies for "rebranding" the disease and alleviating stigma toward migraine. RECENT FINDINGS: Recent literature on condition rebranding offers strategies on how to define and communicate migraine to the public. Rebranding of migraine to alleviate societal stigma is paramount. This involves use of unified language, education, and advocacy.
Migraine is a prevalent disease with a substantial socioeconomic impact. However, stigma affects social attitude toward migraine, accruing additional burden on individuals with migraine and isolating them from a society that should be supporting them. PURPOSE OF THIS REVIEW: This review will discuss the following concepts: (1) the emergence of stigma toward migraine and its impact on medical care; (2) internalized stigma among those with migraine and its detrimental effect on quality of life and patient-physician relationships; (3) the structural impact of stigma on research funding, workplace support, and specialized care; and (4) strategies for "rebranding" the disease and alleviating stigma toward migraine. RECENT FINDINGS: Recent literature on condition rebranding offers strategies on how to define and communicate migraine to the public. Rebranding of migraine to alleviate societal stigma is paramount. This involves use of unified language, education, and advocacy.
Authors: Michael Stokes; Werner J Becker; Richard B Lipton; Sean D Sullivan; Teresa K Wilcox; Leandra Wells; Aubrey Manack; Irina Proskorovsky; Jonathan Gladstone; Dawn C Buse; Sepideh F Varon; Peter J Goadsby; Andrew M Blumenfeld Journal: Headache Date: 2011 Jul-Aug Impact factor: 5.887
Authors: Deepa Rao; Seung W Choi; David Victorson; Rita Bode; Amy Peterman; Allen Heinemann; David Cella Journal: Qual Life Res Date: 2009-04-25 Impact factor: 4.147
Authors: R B Lipton; M E Bigal; S R Rush; J P Yenkosky; J N Liberman; J D Bartleson; S D Silberstein Journal: Neurology Date: 2004-06-08 Impact factor: 9.910
Authors: Henri Autio; Timo Purmonen; Samu Kurki; Emina Mocevic; Minna A Korolainen; Samuli Tuominen; Mariann I Lassenius; Markku Nissilä Journal: Neurol Ther Date: 2021-12-10
Authors: Robert P Cowan; Michael J Marmura; Hans-Christoph Diener; Amaal J Starling; Jack Schim; Joe Hirman; Thomas Brevig; Roger Cady Journal: J Headache Pain Date: 2022-09-06 Impact factor: 8.588
Authors: Scott W Powers; Christopher S Coffey; Leigh A Chamberlin; Dixie J Ecklund; Elizabeth A Klingner; Jon W Yankey; James L Peugh; Leslie L Korbee; Kerry Simmons; Stephanie M Sullivan; Marielle A Kabbouche; Joanne Kacperski; Linda L Porter; Brooke L Reidy; Andrew D Hershey Journal: JAMA Netw Open Date: 2021-07-01